FR2446289B1 - - Google Patents

Info

Publication number
FR2446289B1
FR2446289B1 FR8000243A FR8000243A FR2446289B1 FR 2446289 B1 FR2446289 B1 FR 2446289B1 FR 8000243 A FR8000243 A FR 8000243A FR 8000243 A FR8000243 A FR 8000243A FR 2446289 B1 FR2446289 B1 FR 2446289B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8000243A
Other languages
French (fr)
Other versions
FR2446289A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FR2446289A1 publication Critical patent/FR2446289A1/fr
Application granted granted Critical
Publication of FR2446289B1 publication Critical patent/FR2446289B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04Preparation
    • C07D499/06Preparation by forming the ring or condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR8000243A 1979-01-10 1980-01-07 Compose de 2-penem, procede de preparation et composition pharmaceutique obtenue Granted FR2446289A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US247179A 1979-01-10 1979-01-10
US6287579A 1979-08-01 1979-08-01
US9161079A 1979-11-05 1979-11-05

Publications (2)

Publication Number Publication Date
FR2446289A1 FR2446289A1 (fr) 1980-08-08
FR2446289B1 true FR2446289B1 (US08063081-20111122-C00115.png) 1983-08-19

Family

ID=27357170

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8000243A Granted FR2446289A1 (fr) 1979-01-10 1980-01-07 Compose de 2-penem, procede de preparation et composition pharmaceutique obtenue

Country Status (39)

Country Link
EP (1) EP0013662B1 (US08063081-20111122-C00115.png)
JP (1) JPS55105686A (US08063081-20111122-C00115.png)
KR (1) KR840000606B1 (US08063081-20111122-C00115.png)
AU (1) AU539785B2 (US08063081-20111122-C00115.png)
BE (1) BE881012A (US08063081-20111122-C00115.png)
CA (1) CA1179327A (US08063081-20111122-C00115.png)
CH (1) CH651047A5 (US08063081-20111122-C00115.png)
CS (1) CS214690B2 (US08063081-20111122-C00115.png)
CY (1) CY1323A (US08063081-20111122-C00115.png)
DD (1) DD152339A5 (US08063081-20111122-C00115.png)
DE (1) DE3000343A1 (US08063081-20111122-C00115.png)
DK (1) DK6180A (US08063081-20111122-C00115.png)
ES (1) ES8102131A1 (US08063081-20111122-C00115.png)
FI (1) FI800046A (US08063081-20111122-C00115.png)
FR (1) FR2446289A1 (US08063081-20111122-C00115.png)
GB (1) GB2042520B (US08063081-20111122-C00115.png)
GR (1) GR78057B (US08063081-20111122-C00115.png)
HK (1) HK12786A (US08063081-20111122-C00115.png)
HU (1) HU182661B (US08063081-20111122-C00115.png)
IE (1) IE49879B1 (US08063081-20111122-C00115.png)
IL (1) IL59081A0 (US08063081-20111122-C00115.png)
IT (1) IT1130184B (US08063081-20111122-C00115.png)
KE (1) KE3586A (US08063081-20111122-C00115.png)
LU (1) LU82066A1 (US08063081-20111122-C00115.png)
MW (1) MW180A1 (US08063081-20111122-C00115.png)
MY (2) MY8500052A (US08063081-20111122-C00115.png)
NL (1) NL8000077A (US08063081-20111122-C00115.png)
NO (1) NO158540C (US08063081-20111122-C00115.png)
NZ (1) NZ192542A (US08063081-20111122-C00115.png)
OA (1) OA06428A (US08063081-20111122-C00115.png)
PH (1) PH21780A (US08063081-20111122-C00115.png)
PL (1) PL221289A1 (US08063081-20111122-C00115.png)
PT (1) PT70666A (US08063081-20111122-C00115.png)
RO (1) RO79720A (US08063081-20111122-C00115.png)
SE (1) SE8000105L (US08063081-20111122-C00115.png)
SG (1) SG94885G (US08063081-20111122-C00115.png)
SU (1) SU1053754A3 (US08063081-20111122-C00115.png)
YU (1) YU3180A (US08063081-20111122-C00115.png)
ZA (1) ZA8086B (US08063081-20111122-C00115.png)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880793A (en) * 1978-07-24 1989-11-14 Merck & Co., Inc. Combination of thienamycin-type antibiotics with dipeptidase inhibitors
US5071843A (en) * 1978-07-24 1991-12-10 Merck & Co., Inc. Combination of 2-substituted carbapenems with dipeptidase inhibitors
US4397783A (en) * 1979-03-05 1983-08-09 Pfizer Inc. Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners
JPS55153789A (en) * 1979-04-11 1980-11-29 Sankyo Co Ltd Penem-3-carboxylic acid derivative and its preparation
IE49770B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
EP0035188B1 (en) * 1980-02-28 1985-04-17 Schering Corporation 2-penem compounds, pharmaceutical compositions containing them and methods for their preparation
SE8101464L (sv) * 1980-03-10 1981-09-11 Sankyo Co 2-penem-3-karboxylsyraderivat, deras framstellning och anvendning
JPS56142283A (en) * 1980-03-17 1981-11-06 Sankyo Co Ltd Penem-3-carboxylic acid derivative and its preparation
US4511512A (en) * 1980-05-01 1985-04-16 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Produktionsaktiensel skab) Substantially pure dicyclohexyl ammonium 6-β-bromo-penicillanate
CH651037A5 (de) * 1980-06-06 1985-08-30 Sankyo Co Penem-3-carbonsaeurederivate und verfahren zu deren herstellung.
EP0046363B1 (en) * 1980-08-16 1984-11-14 Beecham Group Plc Process for the preparation of 2-thio penem derivatives and intermediates therefor
US4347183A (en) * 1981-02-02 1982-08-31 Schering Corporation Process for the synthesis of penems and carbapenems
EP0180252B1 (en) * 1981-07-15 1989-04-26 Sumitomo Pharmaceuticals Company, Limited Process of preparing azetidinone compounds
CA1190236A (en) 1981-10-23 1985-07-09 Edward J.J. Grabowski Antibiotic synthesis
JPS595189A (ja) * 1982-07-01 1984-01-12 Sankyo Co Ltd カルバペネム−3−カルボン酸誘導体およびペネム−3−カルボン酸誘導体ならびにそれらの製法
EP0345827A1 (en) * 1982-11-29 1989-12-13 Schering Corporation Process for the production of penem compounds
US4530793A (en) * 1982-11-29 1985-07-23 Schering Corporation Processes for the production of penems
US4675317A (en) * 1983-01-25 1987-06-23 Merck & Co., Inc. 2-unsaturated alkylthio-pen-2-em-3-carboxylic acids
US4610823A (en) * 1983-01-25 1986-09-09 Merck & Co., Inc. Process for preparing substituted 2-thioxopenams and 2-substituted thiopenems
DK141784A (da) * 1983-03-14 1984-09-15 Schering Corp Penemforbindelser, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
US4504485A (en) * 1983-04-04 1985-03-12 Schering Corporation 5R,6S,8R-6-(1-Hydroxyethyl)-2-(2-carbamoyloxyethylthio)-penem-3-carboxylic acid
US4619783A (en) * 1983-06-10 1986-10-28 Pfizer Inc. Process and intermediates for the preparation of penem derivatives
US4725678A (en) * 1983-06-10 1988-02-16 Pfizer Inc. Azetidinone intermediates for the preparation of penem derivatives
US4595539A (en) * 1983-06-10 1986-06-17 Pfizer Inc. Preparation of penem derivatives and azetidinone intermediates
US4554103A (en) * 1983-07-14 1985-11-19 Schering Corporation Preparation of 4-acyloxyazetidinones from acyl nitrates and penams
EP0132101A1 (en) * 1983-07-14 1985-01-23 Pfizer Inc. 2-Heterocycloalkylthiopenem derivatives
US4711886A (en) * 1984-07-02 1987-12-08 Merck & Co., Inc. β-lactam derivatives as anti-inflammatory and antidegenerative agents
US4761408A (en) * 1984-11-02 1988-08-02 Ciba-Geigy Corporation Crystalline aminomethyl compound
SG45180A1 (en) * 1987-02-17 1998-01-16 Ciba Geigy Ag A process for the manufacture of 4-acetoxy-3- hydroxy-ethyl-azetidinone
US4876365A (en) * 1988-12-05 1989-10-24 Schering Corporation Intermediate compounds for preparing penems and carbapenems
EP0567949B1 (en) * 1992-04-28 2001-02-21 Tanabe Seiyaku Co., Ltd. Method for removing silyl protecting groups for hydroxy group
US5587474A (en) * 1992-06-18 1996-12-24 Tanabe Seiyaku Co., Ltd. Method for removing the protecting group for carboxyl group
GB9216102D0 (en) * 1992-07-29 1992-09-09 Smithkline Beecham Plc Pharmaceutical substances
KR100495010B1 (ko) * 2002-01-22 2005-06-13 정명구 정미기
CN115197241B (zh) * 2021-04-08 2023-11-17 四川汇宇制药股份有限公司 一种6,6-二溴青霉烷酸的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (US08063081-20111122-C00115.png) * 1977-05-09 1979-01-18
US4168314A (en) * 1977-11-17 1979-09-18 Merck & Co., Inc. 6-(1'-Hydroxyethyl)-2-aminoethylthio-pen-2-em-3-carboxylic acid
EP0042026B1 (de) * 1978-02-02 1986-01-08 Ciba-Geigy Ag 3,4-Disubstituierte Azetidin-2-onverbindungen und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
IE800034L (en) 1980-07-10
IT8019049A0 (it) 1980-01-07
LU82066A1 (de) 1980-08-08
IT1130184B (it) 1986-06-11
ZA8086B (en) 1980-09-24
SE8000105L (sv) 1980-07-11
PH21780A (en) 1988-02-24
FI800046A (fi) 1980-07-11
JPS55105686A (en) 1980-08-13
DD152339A5 (de) 1981-11-25
AU5438080A (en) 1980-07-17
PL221289A1 (US08063081-20111122-C00115.png) 1980-12-01
NL8000077A (nl) 1980-07-14
SG94885G (en) 1986-07-25
BE881012A (fr) 1980-07-07
PT70666A (en) 1980-02-01
RO79720A (ro) 1982-08-17
DE3000343A1 (de) 1980-07-31
HK12786A (en) 1986-02-28
NO158540B (no) 1988-06-20
CS214690B2 (en) 1982-05-28
CY1323A (en) 1986-06-27
NZ192542A (en) 1984-10-19
AU539785B2 (en) 1984-10-18
CH651047A5 (de) 1985-08-30
KE3586A (en) 1986-02-07
MY8600465A (en) 1986-12-31
ES487488A0 (es) 1980-12-16
DK6180A (da) 1980-07-11
KR830001942A (ko) 1983-05-19
YU3180A (en) 1983-10-31
IL59081A0 (en) 1980-05-30
ES8102131A1 (es) 1980-12-16
GR78057B (US08063081-20111122-C00115.png) 1984-09-26
NO158540C (no) 1988-09-28
NO800030L (no) 1980-07-11
GB2042520B (en) 1983-01-26
OA06428A (fr) 1981-07-31
MY8500052A (en) 1985-12-31
IE49879B1 (en) 1986-01-08
KR840000606B1 (ko) 1984-04-28
MW180A1 (en) 1981-04-08
SU1053754A3 (ru) 1983-11-07
EP0013662A1 (en) 1980-07-23
CA1179327A (en) 1984-12-11
HU182661B (en) 1984-02-28
EP0013662B1 (en) 1983-04-13
FR2446289A1 (fr) 1980-08-08
GB2042520A (en) 1980-09-24

Similar Documents

Publication Publication Date Title
FR2446289B1 (US08063081-20111122-C00115.png)
FR2447310B1 (US08063081-20111122-C00115.png)
BR8002583A (US08063081-20111122-C00115.png)
FR2446954B1 (US08063081-20111122-C00115.png)
BR8006808A (US08063081-20111122-C00115.png)
FR2448739B1 (US08063081-20111122-C00115.png)
FR2448087B1 (US08063081-20111122-C00115.png)
FR2448472B1 (US08063081-20111122-C00115.png)
FR2449045B3 (US08063081-20111122-C00115.png)
FR2447849B1 (US08063081-20111122-C00115.png)
FR2447755B1 (US08063081-20111122-C00115.png)
FR2450186B1 (US08063081-20111122-C00115.png)
DE2949305C2 (US08063081-20111122-C00115.png)
FR2449853B1 (US08063081-20111122-C00115.png)
FR2445842B1 (US08063081-20111122-C00115.png)
FR2445970B1 (US08063081-20111122-C00115.png)
FR2447267B1 (US08063081-20111122-C00115.png)
AU79558S (US08063081-20111122-C00115.png)
AU79559S (US08063081-20111122-C00115.png)
AU78385S (US08063081-20111122-C00115.png)
AU78386S (US08063081-20111122-C00115.png)
AU78389S (US08063081-20111122-C00115.png)
AU78390S (US08063081-20111122-C00115.png)
AU78391S (US08063081-20111122-C00115.png)
AU78569S (US08063081-20111122-C00115.png)

Legal Events

Date Code Title Description
ST Notification of lapse